Tag Archives: Drew Burdon

Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment

(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release

EQT Life Sciences and Gimv Lead €30M Series C Round for Onera Health to Advance Sleep Diagnostics

(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million) Series C financing round. The funding was led by EQT Life Sciences and co-led by Gimv, with participation from existing … Read the full press release